bluebird bio, Inc. (BLUE) Social Stream
bluebird bio Inc (BLUE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BLUE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 14 | $45 | $11 | $23.09 | $4.96 | 365.52% |
| 2021-11-15 | 14 | $45 | $11 | $22.8 | $4.96 | 359.68% |
| 2021-11-19 | 14 | $45 | $11 | $20.2 | $4.96 | 307.26% |
| 2021-12-20 | 13 | $45 | $11 | $20.2 | $4.96 | 307.26% |
| 2022-01-06 | 13 | $45 | $10 | $20.1 | $4.96 | 305.24% |
| 2022-01-18 | 13 | $45 | $10 | $19.9 | $4.96 | 301.21% |
| 2022-02-01 | 13 | $45 | $6 | $19.5 | $4.96 | 293.15% |
| 2022-03-07 | 12 | $45 | $6 | $19.5 | $4.96 | 293.15% |
| 2022-03-09 | 13 | $45 | $4 | $18.333 | $4.96 | 269.62% |
The Trend in the Analyst Price Target
BLUE's average price target has moved down $87.43 over the prior 18 months.
Over the past 121 days, BLUE's average upside potential has been 176.72%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 14 | 45 | 11 | 23.090 | 10.70 | 115.79% |
| 2021-11-08 | 14 | 45 | 11 | 23.600 | 10.70 | 120.56% |
| 2022-01-18 | 13 | 45 | 10 | 19.900 | 7.91 | 151.58% |
| 2022-03-09 | 13 | 45 | 4 | 17.900 | 4.84 | 269.83% |
| 2022-03-09 | 13 | 45 | 4 | 18.333 | 4.84 | 278.78% |
BLUE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.95 | 2 | 0 | 9 | 2 | 2 | 13 |
The Trend in the Broker Recommendations
Over the past 59 days, BLUE's average broker recommendation rating worsened by 0.15.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- BLUE has a lower variance in analysts' estimates than -1182.85% of all US stocks.
- In the context of stocks in the large market cap category, bluebird bio Inc's upside potential (average analyst target price relative to current price) is greater than 1288.96% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, bluebird bio Inc's average analyst price target is higher than 117.48% of them.
- In terms of how bluebird bio Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 1152.98% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to bluebird bio Inc are BIIB, ARGX, and AMGN.
What is the outlook for BLUE? Use POWR Ratings for clearer insight into price direction.